My results from meeting with former FDA panel Dr.
1. Reviewed ARYC website and their statements to date.
2. What ARYC is doing is a "tool" of highly specialized needs in medicine today, and there are many tools out there, yet this is highly specific.
3. From point of "ARYC" wanting investors to buy their stock, they need to provide information of which serious investors can judge and make investment by- there simply is no public information being provided.
4. ARYC is small but what they tout is highly specialized and needed, so bosts a possible buyout by one of the majors for what they do have "if proven".
5. ARYC's BOD may want to stay OTC, not uplist, because it makes them more monies; and to uplist would then require them to live a stringent reporting regiment for SEC and exchanges thereafter.
6. With ARYC's 25 year history in business now, and what ARYC purports to have ongoing, it makes one wonder why they are still OTC, when a real exchange can be very beneficial for any company and its shareholders alike.
7. Regardless of still being an OTC "penny stock", they would do well to bolster further investment if they did a share buyback to reduce insane amount of stock they show out there. And simply not getting any salient answers to many questions, and their vagueness on tweets, is unusual even in this industry, even though the technology and procedures to get FDA approvals and the like can/are done in a very "quiet" type process highly protected...
8. If you do not see anything forthcoming by end of this month based on public information and/or filings from ARYC and their CEO in particular, take your money out of this company and go elsewhere to companies who can and do provide regular public information of their operations.
9. As far as bookkeeping and financial readiness docs, etc regardless of certain basic time frames and delays that can occur, it generally can be done rather quickly today with any proper respectable accounting/record keeping type firm and is done every day all the time for other similar type industry players... No need to take forever as is what seems to be happening with this company. And again, with no release of any type information publicly like any respectable industry player would do, nobody can make judgement where things lay here.
AI
